Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Fleischer

Showing results (51-60 of 569) with videos related to

Pageof 57
Sort By:
The Journal of Experimental Medicine|May 1, 1988
T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cellsB Fleischer, H Schrezenmeier
Journal of Drugs in Dermatology : JDD|October 15, 2010
Vehicle or placebo? Investigators use incorrect terminology in randomized controlled trials half of the time: a systematic review of randomized controlled trials published in three major dermatology journalsNorashikin Shamsudin, Alan B Fleischer
The Journal of Dermatological Treatment|July 10, 2020
Increased biologic utilization in Latino patients with psoriasisTammy Gonzalez, Alan B Fleischer
The Journal of Dermatological Treatment|February 13, 2020
United States systemic psoriasis treatments: increases in the use of biologic agents and plateau of methotrexate and oral small molecule inhibitorsSuraj Muddasani, Alan B Fleischer
The Journal of Dermatological Treatment|February 20, 2020
Assessing adherence to evidence-based guidelines of care for acne vulgarisSpencer Dunaway, Alan B Fleischer
Journal of Clinical Medicine|September 14, 2024
IL-17 and IL-23 Inhibitors Have the Fastest Time to Meaningful Clinical Response for Plaque Psoriasis: A Network Meta-AnalysisPushkar Aggarwal, Alan B Fleischer
Medical Microbiology and Immunology|January 1, 1992
Recombinant epidermolytic (exfoliative) toxin A of Staphylococcus aureus is not a superantigenB Fleischer, C J Bailey
Clinical and Experimental Immunology|March 1, 1990
Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosisK H Enssle, B Fleischer
Human Immunology|August 1, 1983
Clonal expansion and functional analysis of virus-specific T lymphocytes from cerebrospinal fluid in measles encephalitisB Fleischer, H W Kreth
Cellular Immunology|January 1, 1992
Stimulator cell-dependent requirement for CD2- and LFA-1-mediated adhesions in T lymphocyte activation by superantigenic toxinsH W Mittrücker, B Fleischer
Pageof 57

Showing results (51-60 of 569) with videos related to

Sort By:
Pageof 57
The Journal of Experimental Medicine|May 1, 1988
T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cellsB Fleischer, H Schrezenmeier
Journal of Drugs in Dermatology : JDD|October 15, 2010
Vehicle or placebo? Investigators use incorrect terminology in randomized controlled trials half of the time: a systematic review of randomized controlled trials published in three major dermatology journalsNorashikin Shamsudin, Alan B Fleischer
The Journal of Dermatological Treatment|July 10, 2020
Increased biologic utilization in Latino patients with psoriasisTammy Gonzalez, Alan B Fleischer
The Journal of Dermatological Treatment|February 13, 2020
United States systemic psoriasis treatments: increases in the use of biologic agents and plateau of methotrexate and oral small molecule inhibitorsSuraj Muddasani, Alan B Fleischer
The Journal of Dermatological Treatment|February 20, 2020
Assessing adherence to evidence-based guidelines of care for acne vulgarisSpencer Dunaway, Alan B Fleischer
Journal of Clinical Medicine|September 14, 2024
IL-17 and IL-23 Inhibitors Have the Fastest Time to Meaningful Clinical Response for Plaque Psoriasis: A Network Meta-AnalysisPushkar Aggarwal, Alan B Fleischer
Medical Microbiology and Immunology|January 1, 1992
Recombinant epidermolytic (exfoliative) toxin A of Staphylococcus aureus is not a superantigenB Fleischer, C J Bailey
Clinical and Experimental Immunology|March 1, 1990
Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosisK H Enssle, B Fleischer
Human Immunology|August 1, 1983
Clonal expansion and functional analysis of virus-specific T lymphocytes from cerebrospinal fluid in measles encephalitisB Fleischer, H W Kreth
Cellular Immunology|January 1, 1992
Stimulator cell-dependent requirement for CD2- and LFA-1-mediated adhesions in T lymphocyte activation by superantigenic toxinsH W Mittrücker, B Fleischer
Pageof 57